Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease

Pharmacology Biochemistry and Behavior

Volumn 140, Issue , 2016, Pages 39-50

  Jayant, Shalini ^a   Sharma, Brij Mohan ^a   Bansal, Rani ^b   Sharma, Bhupesh ^c,d  

^a BHARAT INSTITUTE OF TECHNOLOGY   (India)

^b SWAMI VIVEKANAND SUBHARTI UNIVERSITY   (India)

^c AMITY UNIVERSITY   (India)

^d Dilshad Garden   (India)

Author keywords

1 Phenylisatin; Aluminum trichloride; Attentional set shifting test; Image J; Morris water maze; Myeloperoxidase; Streptozotocin

Indexed keywords

1 PHENYLISATIN; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CALCIUM; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CONGO RED; DONEPEZIL; GALACTOSE; GLUTATHIONE; MYELOPEROXIDASE; NITRIC ACID DERIVATIVE; NITRITE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; ALUMINUM CHLORIDE; ALUMINUM DERIVATIVE; CHLORIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN BIOCHEMISTRY; BRAIN DAMAGE; CALCIUM BLOOD LEVEL; CHOLINERGIC ACTIVITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; EXECUTIVE FUNCTION; FEMALE; GRIP STRENGTH; HISTOPATHOLOGY; INFLAMMATION; LATENT PERIOD; LEARNING; LOCOMOTION; MALE; MEMORY ASSESSMENT; MORRIS WATER MAZE TEST; MOTOR COORDINATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; AMYLOID PLAQUE; ANIMAL; ATTENTION; BRAIN; BRAIN CHEMISTRY; CHEMICALLY INDUCED; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MAZE TEST; MEMORY; MOUSE; PATHOLOGY; PSYCHOLOGY;

ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; ASSOCIATION LEARNING; ATTENTION; BRAIN; BRAIN CHEMISTRY; CHLORIDES; EXECUTIVE FUNCTION; FEMALE; GALACTOSE; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; MICE; OXIDATIVE STRESS; PLAQUE, AMYLOID; RECEPTOR, CANNABINOID, CB2; STREPTOZOCIN;

EID: 84947776514     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.11.006     Document Type: Article

References (82)

1. A.E. Abdel Moneim, M.S. Othman, S.M. Mohmoud, and K.M. El-Deib Pomegranate peel attenuates aluminum-induced hepatorenal toxicity Toxicol. Mech. Methods 23 8 2013 624 633
2. S. Adhikary, V.P. Kocieda, J.H. Yen, R.F. Tuma, and D. Ganea Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression Blood 120 18 2012 3741 3749
3. I.M. Ahmed, H. Dai, W. Zheng, F. Cao, G. Zhang, D. Sun, and F. Wu Genotypic differences in physiological characteristics in the tolerance to drought and salinity combined stress between Tibetan wild and cultivated barley Plant Physiol. Biochem. 63 2013 49 60
4. H.A. Ali, M. Afifi, A.M. Abdelazim, and Y.Y. Mosleh Quercetin and omega 3 ameliorate oxidative stress induced by aluminium chloride in the brain J. Mol. Neurosci. 53 4 2014 654 660
5. A. Aliabadi, A. Foroumadi, A. Mohammadi-Farani, and M.M. Garmsiri Synthesis and evaluation of anti-acetylcholinesterase activity of 2-(2-(4-(2-oxo-2-phenylethyl)piperazin-1-yl) ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects Iran J. Basic Med. Sci. 16 10 2013 1049 1054
6. H.F. Aly, F.M. Metwally, and H.H. Ahmed Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease Acta Biochim. Pol. 58 4 2011 513 520
7. J.C. Ashton, R.M. Rahman, S.M. Nair, B.A. Sutherland, M. Glass, and I. Appleton Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain Neurosci. Lett. 412 2 2007 114 117
8. E. Aso, and I. Ferrer Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic Front. Pharmacol. 5 2014 5 37
9. J.D. Bancroft, and M. Gamble Theory and Practice of Histopathologic Techniques 7th edition 270-272 2013 Churchill Livingstone Elsevier Philadelphia
10. J.M. Birrell, and V.J. Brown Medial frontal cortex mediates perceptual attentional set shifting in the rat J. Neurosci. 20 11 2000 4320 4324
11. A. Bruno, F. Lembo, E. Novellino, M. Stornaiuolo, and L. Marinelli Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay Sci. Report. 4 2014 3757
12. A. Caballero, and K.Y. Tseng Association of cannabis use during adolescence, prefrontal CB1 receptor signaling, and schizophrenia Front. Pharmacol. 3 2012 101
13. A. Campbell, A. Becaria, D.K. Lahiri, K. Sharman, and S.C. Bondy Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain J. Neurosci. Res. 75 4 2004 565 572
14. Chae YJ, Lee HJ, Jeon JH, Kim IB, Choi JS4, Sung KW, Hahn SJ. Effects of donepezil on hERG potassium channels. Brain Res. 2014. (PMID: 25498859). pii: S0006-8993(14)01664-3. doi: http://dx.doi.org/10.1016/j.brainres.2014.11.057.
15. M. Chakrabarty, P. Bhat, S. Kumari, A. D'Souza, K.L. Bairy, A. Chaturvedi, A. Natarajan, M.K. Rao, and S. Kamath Cortico-hippocampal salvage in chronic aluminium induced neurodegeneration by Celastrus paniculatus seed oil: neurobehavioural, biochemical, histological study J. Pharmacol. Pharmacother. 3 2 2012 161 171
16. S.R. Childers, M.A. Pacheco, B.A. Bennett, T.A. Edwards, R.E. Hampson, J. Mu, and S.A. Deadwyler Cannabinoid receptors: G-protein-mediated signal transduction mechanisms Biochem. Soc. Symp. 59 1993 27 50
17. I.Y. Choi, C. Ju, A.M. Anthony Jalin, I. Lee da, P.L. Prather, and W.K. Kim Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury Am. J. Pathol. 182 3 2013 928 939
18. G. Colacicco, H. Welzl, H.P. Lipp, and H. Würbel Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation Behav. Brain Res. 132 1 2002 95 102
19. A. Contartese, M. Valoti, F. Corelli, S. Pasquini, C. Mugnaini, F. Pessina, C. Aldinucci, G. Sgaragli, and M. Frosini A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury Pharmacol. Res. 66 6 2012 555 563
20. S.C. Correia, R.X. Santos, M.S. Santos, G. Casadesus, J.C. Lamanna, G. Perry, M.A. Smith, and P.I. Moreira Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease Curr. Alzheimer Res. 10 4 2013 406 419
21. D. De Filippis, G. Esposito, C. Cirillo, M. Cipriano, B.Y. De Winter, C. Scuderi, G. Sarnelli, R. Cuomo, L. Steardo, J.G. De Man, and T. Iuvone Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis PLoS One 6 12 2011 e28159
22. S.M. de la Monte, and M. Tong Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease J. Alzheimers Dis. 17 4 2009 817 825
23. F.S. den Boon, T.R. Werkman, Q. Schaafsma-Zhao, K. Houthuijs, T. Vitalis, C.G. Kruse, W.J. Wadman, and P. Chameau Activation of Type-1 Cannabinoid Receptor Shifts the Balance Between Excitation and Inhibition Towards Excitation in Layer II/III Pyramidal Neurons of the Rat Prelimbic Cortex 2014 Pflugers Arch (PMID: 25081244)
24. Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D (2014) Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. Epilepsia doi: http://dx.doi.org/10.1111/epi.12631. (PMID: 24854329).
25. D.K. Dhull, D. Bhateja, R.K. Dhull, and S.S. Padi Differential role of cyclooxygenase isozymes on neuronal density in hippocampus CA1 region of intracerebroventricular streptozotocin treated rat brain J. Chem. Neuroanat. 43 1 2012 48 51
26. H. Elçioʇlu, L. Kabasakal, S. Alan, E. Salva, F. Tufan, and M. Karan Thalidomide attenuates learning and memory deficits induced by intracerebroventricular administration of streptozotocin in rats Biotech. Histochem. 88 3-4 2013 145 152
27. S.G. Fagan, and V.A. Campbell The influence of cannabinoids on generic traits of neurodegeneration Br. J. Pharmacol. 171 6 2014 1347 1360
28. M.S. García-Ayllón, I. Riba-Llena, C. Serra-Basante, J. Alom, R. Boopathy, and J. Sáez-Valero Altered levels of acetylcholinesterase in Alzheimer plasma PLoS One 5 1 2010 e8701
29. M.S. García-Gutiérrez, and J. Manzanares Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice J. Psychopharmacol. 25 1 2011 111 120
30. M.S. García-Gutiérrez, A. Ortega-Álvaro, A. Busquets-García, J.M. Pérez-Ortiz, L. Caltana, M.J. Ricatti, A. Brusco, R. Maldonado, and J. Manzanares Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors Neuropharmacology 73 2013 388 396
31. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120 3 1984 885 890
32. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski, and L.I. Binder Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc. Natl. Acad. Sci. U. S. A. 83 13 1986 4913 4917
33. S. Han, J.J. Chen, and J.Z. Chen Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor Mini-Rev. Med. Chem. 14 5 2014 426 443
34. K.J. Kwon, M.K. Kim, E.J. Lee, J.N. Kim, B.R. Choi, S.Y. Kim, K.S. Cho, J.S. Han, H.Y. Kim, C.Y. Shin, and S.H. Han Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia J. Neurol. Sci. 347 1-2 2014 66 77
35. Y1. Li, Y.B. Dai, J.Y. Sun, Y. Xiang, J. Yang, S.Y. Dai, and X. Zhang Neuroglobin attenuates beta amyloid-induced apoptosis through inhibiting caspases activity by activating PI3K/Akt signaling pathway J. Mol. Neurosci. 2015 (PMID: 26346601)
36. I. Magen, Y. Avraham, Z. Ackerman, L. Vorobiev, R. Mechoulam, and E.M. Berry Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation J. Hepatol. 51 3 2009 528 534
37. A.S. Majumdar, A. Nirwane, and R. Kamble Coenzyme q10 abrogated the 28 days aluminium chloride induced oxidative changes in rat cerebral cortex Toxicol. Int. 21 2 2014 214 221
38. E.B. Manukhina, A.V. Goriacheva, I.V. Barskov, I.V. Viktorov, A.A. Guseva, M.G. Pshennikova, I.P. Khomenko, S.I. Mashina, D.A. Pokidyshev, and M. Iiu Prevention of the brain neurodegeneration in rats with experimental Alzheimer's disease by adaptation to hypoxia Ross Fiziol Zh Im I M Sechenova 95 7 2009 706 715
39. X.Y. Mao, D.F. Cao, X. Li, J.Y. Yin, Z.B. Wang, Y. Zhang, C.X. Mao, H.H. Zhou, and Z.Q. Liu Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic rats Int. J. Mol. Sci. 15 5 2014 7667 7683
40. I. Molino, L. Colucci, A.M. Fasanaro, E. Traini, and F. Amenta Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials ScientificWorldJournal 2013 10.1155/2013/925702 (PMID: 24288512)
41. M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, and R. Ghasemi Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption Eur. J. Pharmacol. 736 2014 107 114
42. P.I. Moreira, A.P. Rolo, C. Sena, R. Seiça, C.R. Oliveira, and M.S. Santos Insulin attenuates diabetes-related mitochondrial alterations: a comparative study Med. Chem. 2 3 2006 299 308
43. N.H. Morgan, I.M. Stanford, and G.L. Woodhall Functional CB2 type cannabinoid receptors at CNS synapses Neuropharmacology 57 4 2009 356 368
44. M. Nivsarkar, and A. Banerjee Establishing the probable mechanism of l-DOPA in Alzheimer's disease management Acta Pol. Pharm. 66 5 2009 483 486
45. J. Palazuelos, T. Aguado, M.R. Pazos, B. Julien, C. Carrasco, E. Resel, O. Sagredo, C. Benito, J. Romero, I. Azcoitia, J. Fernández-Ruiz, M. Guzmán, and I. Galve-Roperh Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity Brain 132 Pt 11 2009 3152 3164
46. R. Pan, S. Qiu, D.X. Lu, and J. Dong Curcumin improves learning and memory ability and its neuroprotective mechanism in mice Chin. Med. J. 121 9 2008 832 839
47. A.F. Pike, N.I. Kramer, B.J. Blaauboer, W. Seinen, and R. Brands An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer's disease and neurodegeneration Chem. Biol. Interact. 226C 2015 30 39
48. N. Rajasekar, S. Dwivedi, C. Nath, K. Hanif, and R. Shukla Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin Neuropharmacology 86 2014 337 352
49. C. Remya, K.V. Dileep, I. Tintu, E.J. Variyar, and C. Sadasivan Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence Indian J. Pharm. Sci. 76 6 2014 567 570
50. D. Riascos, D. de Leon, A. Baker-Nigh, A. Nicholas, R. Yukhananov, J. Bu, C.K. Wu, and C. Geula Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease Acta Neuropathol. 122 5 2011 565 576 10.1007/s00401-011-0865-4 Epub 2011 Aug 27
51. J.R. Rivers-Auty, P.F. Smith, and J.C. Ashton The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats Neurosci. Lett. 569 2014 104 109
52. A. Romero, E. Ramos, R.C. de Los, J. Egea, J. Del Pino, and R.J. Reiter A review of metal-catalyzed molecular damage: protection by melatonin J. Pineal Res. 56 4 2014 343 370
53. A. Rozycka, P.P. Jagodzinski, W. Kozubski, M. Lianeri, and J. Dorszewska Homocysteine level and mechanisms of injury in Parkinson's disease as related to MTHFR, MTR, and MTHFD1 genes polymorphisms and l-dopa treatment Curr. Genomics 14 8 2013 534 542
54. J. Sáez-Valero, G. Sberna, C.A. McLean, and D.H. Small Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease J. Neurochem. 72 4 1999 1600 1608
55. B. Sharma, and N. Singh Pitavastatin and 4′-hydroxy-3′-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes Curr. Neurovasc. Res. 7 3 2010 180 191
56. B. Sharma, and N. Singh Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats Psychopharmacology 215 4 2011 677 687
57. B. Sharma, and N. Singh Experimental hypertension induced vascular dementia: pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor Pharmacol. Biochem. Behav. 102 1 2012 101 108
58. B. Sharma, and N. Singh Salutary effect of NFκB inhibitor and folacin in hyperhomocysteinemia-hyperlipidemia induced vascular dementia Prog. Neuro-Psychopharmacol. Biol. Psychiatry 38 2 2012 207 215
59. B. Sharma, N. Singh, and M. Singh Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil J. Psychopharmacol. 22 2 2008 162 171
60. B. Sharma, N. Singh, M. Singh, and A.S. Jaggi Exploitation of HIV protease inhibitor indinavir as a memory restorative agent in experimental dementia Pharmacol. Biochem. Behav. 89 4 2008 535 545
61. B. Singh, B. Sharma, A.S. Jaggi, and N. Singh Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property J. Renin-Angiotensin-Aldosterone Syst. 14 2 2013 124 136
62. J. Song, B.E. Hur, K.K. Bokara, W. Yang, H.J. Cho, K.A. Park, W.T. Lee, K.M. Lee, and J.E. Lee Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model Yonsei Med. J. 55 3 2014 689 699
63. E. Sreekumaran, T. Ramakrishna, T.R. Madhav, D. Anandh, B.M. Prabhu, S. Sulekha, P.N. Bindu, and T.R. Raju Loss of dendritic connectivity in CA1, CA2, and CA3 neurons in hippocampus in rat under aluminum toxicity: antidotal effect of pyridoxine Brain Res. Bull. 59 6 2003 421 427
64. T. Sumathi, C. Shobana, M. Thangarajeswari, and R. Usha Protective effect of l-theanine against aluminium induced neurotoxicity in cerebral cortex, hippocampus and cerebellum of rat brain - histopathological, and biochemical approach Drug Chem. Toxicol. 2014 (PMID: 24654859)
65. L.J. Sun, X.H. Hou, S.H. Xue, F. Yan, Y.J. Dai, C.H. Zhao, F. Wang, and R.H. Yang Fish oil modulates glycogen synthase kinase-3 signaling pathway in diabetes-induced hippocampal neurons apoptosis Brain Res. 1574 2014 37 49
66. F. Tchantchou, L.B. Tucker, A.H. Fu, R.J. Bluett, J.T. McCabe, S. Patel, and Y. Zhang The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury Neuropharmacology 85 2014 427 439
67. V. Torres-Lista, C. Parrado-Fernández, I. Alvarez-Montón, J. Frontiñán-Rubio, M. Durán-Prado, J.R. Peinado, B. Johansson, F.J. Alcaín, and L. Giménez-Llort Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice Behav. Brain Res. 271 2014 140 146
68. S. Umukoro, F.A. Adewole, A.T. Eduviere, A.O. Aderibigbe, and C. Onwuchekwa Free radical scavenging effect of donepezil as the possible contribution to its memory enhancing activity in mice Drug Res. (Stuttg) 64 5 2014 236 239
69. C. Unsal, M. Oran, Y. Albayrak, C. Aktas, M. Erboga, B. Topcu, R. Uygur, F. Tulubas, O. Yanartas, O. Ates, and O.A. Ozen Neuroprotective effect of ebselen against intracerebroventricular streptozotocin-induced neuronal apoptosis and oxidative stress in rats Toxicol. Ind. Health 2013 (PMID: 24231787)
70. N. VanDuyn, R. Settivari, J. LeVora, S. Zhou, J. Unrine, and R. Nass The metal transporter SMF-3/DMT-1 mediates aluminum-induced dopamine neuron degeneration J. Neurochem. 124 1 2013 147 157
71. H.V. Vinters Emerging concepts in Alzheimer's disease Annu. Rev. Pathol. 2014 (PMID: 25387055)
72. B. Wang, J. Zhao, M. Yu, X. Meng, X. Cui, Y. Zhao, Y. Zhu, W. Xing, and Y. Guan Disturbance of intracellular calcium homeostasis and CaMKII/CREB signaling is associated with learning and memory impairments induced by chronic aluminum exposure Neurotox. Res. 26 1 2014 52 63
73. Z.X. Xi, X.Q. Peng, X. Li, R. Song, H.Y. Zhang, Q.R. Liu, H.J. Yang, G.H. Bi, J. Li, and E.L. Gardner Brain cannabinoid CB receptors modulate cocaine's actions in mice Nat. Neurosci. 14 9 2011 1160 1166
74. Y.F. Xian, Z.X. Lin, M. Zhao, Q.Q. Mao, S.P. Ip, and C.T. Che Uncaria rhynchophylla ameliorates cognitive deficits induced by d-galactose in mice Planta Med. 77 18 2011 1977 1983
75. Q. Yang, H.Y. Liu, Y.W. Zhang, W.J. Wu, and W.X. Tang Anandamide induces cell death through lipid rafts in hepatic stellate cells J. Gastroenterol. Hepatol. 25 5 2010 991 1001
76. W.N. Yang, H. Han, X.D. Hu, G.F. Feng, and Y.H. Qian The effects of perindopril on cognitive impairment induced by d-galactose and aluminum trichloride via inhibition of acetylcholinesterase activity and oxidative stress Pharmacol. Biochem. Behav. 114-115 2013 31 36
77. L. Yang, R. Rozenfeld, D. Wu, L.A. Devi, Z. Zhang, and A. Cederbaum Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy Free Radic. Biol. Med. 68 2014 260 267
78. A. Zaky, B. Mohammad, M. Moftah, K.M. Kandeel, and A.R. Bassiouny Apurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation BMC Neurosci. 4 2013 26
79. J.G. Zarruk, D. Fernández-López, I. García-Yébenes, M.S. García-Gutiérrez, J. Vivancos, F. Nombela, M. Torres, M.C. Burguete, J. Manzanares, I. Lizasoain, and M.A. Moro Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection Stroke 43 1 2012 211 219
80. L. Zhang, C. Jin, Q. Liu, X. Lu, S. Wu, J. Yang, Y. Du, L. Zheng, and Y. Cai Effects of subchronic aluminum exposure on spatial memory, ultrastructure and L-LTP of hippocampus in rats J. Toxicol. Sci. 38 2 2013 255 268
81. L. Zhang, C. Jin, X. Lu, J. Yang, S. Wu, Q. Liu, R. Chen, C. Bai, D. Zhang, L. Zheng, Y. Du, and Y. Cai Aluminium chloride impairs long-term memory and downregulates cAMP-PKA-CREB signalling in rats Toxicology 323 2014 95 108
82. S. Zoppi, J.L. Madrigal, J.R. Caso, M.S. García-Gutiérrez, J. Manzanares, J.C. Leza, and B. García-Bueno Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice Br. J. Pharmacol. 171 11 2014 2814 2826